Tirzexyl 5 mg
Kalpa Pharmaceuticals

Tirzexyl 5 mg

TIRZEXYL 5 MG INJECTION
Drug Class:
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Kalpa Pharmaceuticals

90.00 USD
Shipping From:
International
U.S. Domestic

Tirzexyl 5 mg Detailed

Tirzexyl 5 mg – Kalpa Pharmaceuticals Tirzepatide Peptide

Tirzexyl 5 mg by Kalpa Pharmaceuticals contains research-grade Tirzepatide in a 2 mL vial. Tirzepatide is a dual agonist of the GLP-1 and GIP receptors, studied for its powerful effects on glycemic control and body weight regulation. Known under prescription names like Mounjaro, this compound is being widely researched for its ability to outperform single-action GLP-1 peptides in metabolic applications.

What Is Tirzepatide?

Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist developed for type 2 diabetes and weight management. It mimics incretin hormones that promote insulin secretion, suppress appetite, and slow gastric emptying. As supported by recent peer-reviewed trials, Tirzepatide has demonstrated superior body weight reduction and A1C lowering compared to Semaglutide.

Why Researchers Choose Kalpa Tirzepatide

This dual-incretin peptide offered under the Tirzexyl label by Kalpa Pharmaceuticals is produced for scientific studies exploring appetite modulation, glucose regulation, and fat loss pathways. Researchers value its extended half-life, weekly dosing protocol, and combined GIP/GLP-1 effects in experimental weight reduction models.

Potential Research Applications

  • Investigating dual receptor activation for metabolic enhancement
  • Comparative studies with GLP-1 agonists like Semaglutide
  • Appetite, satiety, and body composition research
  • Support for insulin sensitivity models

Experimental protocols may also include co-administration with Semaglutixyl or Kalptropin to explore combined hormonal effects. For enhanced nutrient partitioning, Oxandroxyl or Clenbutaxyl may be stacked in performance-based trials.

Dosing & Stability

  • Suggested research dose: 2.5–5 mg per week
  • Route: Subcutaneous injection in experimental subjects
  • Storage: Refrigerate between 2–8°C

Kalpa Pharmaceuticals Quality Assurance

Kalpa Pharmaceuticals delivers high-purity research peptides backed by precision synthesis and sterile filtration. This GLP-1/GIP peptide blend offered under the Tirzexyl name meets rigorous research standards and is suited for experimental applications in obesity and metabolic disorders.

Frequently Asked Questions

What is Tirzexyl used for?

Tirzexyl is used in research involving weight loss, glucose regulation, and dual GLP-1/GIP receptor activity. It's under study for obesity and metabolic disorders.

How is Tirzexyl administered in studies?

Tirzexyl is typically administered as a weekly subcutaneous injection in lab-based research models studying metabolic function and fat loss mechanisms.

How does Tirzepatide compare to Semaglutide?

Studies suggest Tirzepatide may lead to greater fat loss and A1C reductions than Semaglutide, due to its dual activation of GIP and GLP-1 receptors.

Can Tirzexyl be stacked with other compounds?

Yes. It may be combined in research with Semaglutixyl, Kalptropin, or Clenbutaxyl to examine synergistic effects on appetite, fat oxidation, and metabolism.

No reviews found

Please log in to write Tirzexyl 5 mg review.

Related Offers
US Domestic & International
Bacteriostatic Water
Kalpa Pharmaceuticals LTD, India

STERILE WATER 0.9% INJECTION
Drug Class:
Composition:
- Active Substance: Sterile Water
- Concentration: 0.9%/vial
Presentation: 2 mL Vial
Manufacturer: Kalpa Pharmaceuticals

25.00 USD  
US Domestic & International
BPC 157 5 mg
Kalpa Pharmaceuticals LTD, India

PENTADECAPEPTIDE 2 MG INJECTION
Drug Class:
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Kalpa Pharmaceuticals

47.00 USD  
US Domestic & International
Semaglutixyl 5 mg
Kalpa Pharmaceuticals LTD, India

SEMAGLUTIDE GLP-1 RA 5 MG INJECTION
Drug Class:
Composition:
- Active Substance: Semaglutide GLP-1 RA
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Kalpa Pharmaceuticals

70.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: